High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease

Dominik Huster, Tina D. Purnat, Jason L. Burkhead, Martina Ralle, Oliver Fiehn, Franziska Stuckert, N. Erik Olson, Daniel Teupser, Svetlana Lutsenko

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Copper is essential for human physiology, but in excess it causes the severe metabolic disorder Wilson disease. Elevated copper is thought to induce pathological changes in tissues by stimulating the production of reactive oxygen species that damage multiple cell targets. To better understand the molecular basis of this disease, we performed genome-wide mRNA profiling as well as protein and metabolite analysis for Atp7b-/- mice, an animal model of Wilson disease. We found that at the presymptomatic stages of the disease, copper-induced changes are inconsistent with widespread radical-mediated damage, which is likely due to the sequestration of cytosolic copper by metallothioneins that are markedly up-regulated in Atp7b-/- livers. Instead, copper selectively up-regulates molecular machinery associated with the cell cycle and chromatin structure and down-regulates lipid metabolism, particularly cholesterol biosynthesis. Specific changes in the transcriptome are accompanied by distinct metabolic changes. Biochemical and mass spectroscopy measurements revealed a 3.6-fold decrease of very low density lipoprotein cholesterol in serum and a 33% decrease of liver cholesterol, indicative of a marked decrease in cholesterol biosynthesis. Consistent with low cholesterol levels, the amount of activated sterol regulatory-binding protein 2 (SREBP-2) is increased in Atp7b-/- nuclei. However, the SREBP-2 target genes are dysregulated suggesting that elevated copper alters SREBP-2 function rather than its processing or re-localization. Thus, in Atp7b-/- mice elevated copper affects specific cellular targets at the transcription and/or translation levels and has distinct effects on liver metabolic function, prior to appearance of histopathological changes. The identification of the network of specific copper-responsive targets facilitates further mechanistic analysis of human disorders of copper misbalance.

Original languageEnglish (US)
Pages (from-to)8343-8355
Number of pages13
JournalJournal of Biological Chemistry
Volume282
Issue number11
DOIs
StatePublished - Mar 16 2007

Fingerprint

Hepatolenticular Degeneration
Lipid Metabolism
Machinery
Copper
Cell Cycle
Cells
Sterols
Cholesterol
Liver
Carrier Proteins
Biosynthesis
Genes
Asymptomatic Diseases
VLDL Cholesterol
Metallothionein
Physiology
Transcription
Metabolites
Transcriptome
Chromatin

ASJC Scopus subject areas

  • Biochemistry

Cite this

High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. / Huster, Dominik; Purnat, Tina D.; Burkhead, Jason L.; Ralle, Martina; Fiehn, Oliver; Stuckert, Franziska; Olson, N. Erik; Teupser, Daniel; Lutsenko, Svetlana.

In: Journal of Biological Chemistry, Vol. 282, No. 11, 16.03.2007, p. 8343-8355.

Research output: Contribution to journalArticle

Huster, D, Purnat, TD, Burkhead, JL, Ralle, M, Fiehn, O, Stuckert, F, Olson, NE, Teupser, D & Lutsenko, S 2007, 'High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease', Journal of Biological Chemistry, vol. 282, no. 11, pp. 8343-8355. https://doi.org/10.1074/jbc.M607496200
Huster, Dominik ; Purnat, Tina D. ; Burkhead, Jason L. ; Ralle, Martina ; Fiehn, Oliver ; Stuckert, Franziska ; Olson, N. Erik ; Teupser, Daniel ; Lutsenko, Svetlana. / High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 11. pp. 8343-8355.
@article{8e4d90e98db9466e94e82b94e12184cb,
title = "High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease",
abstract = "Copper is essential for human physiology, but in excess it causes the severe metabolic disorder Wilson disease. Elevated copper is thought to induce pathological changes in tissues by stimulating the production of reactive oxygen species that damage multiple cell targets. To better understand the molecular basis of this disease, we performed genome-wide mRNA profiling as well as protein and metabolite analysis for Atp7b-/- mice, an animal model of Wilson disease. We found that at the presymptomatic stages of the disease, copper-induced changes are inconsistent with widespread radical-mediated damage, which is likely due to the sequestration of cytosolic copper by metallothioneins that are markedly up-regulated in Atp7b-/- livers. Instead, copper selectively up-regulates molecular machinery associated with the cell cycle and chromatin structure and down-regulates lipid metabolism, particularly cholesterol biosynthesis. Specific changes in the transcriptome are accompanied by distinct metabolic changes. Biochemical and mass spectroscopy measurements revealed a 3.6-fold decrease of very low density lipoprotein cholesterol in serum and a 33{\%} decrease of liver cholesterol, indicative of a marked decrease in cholesterol biosynthesis. Consistent with low cholesterol levels, the amount of activated sterol regulatory-binding protein 2 (SREBP-2) is increased in Atp7b-/- nuclei. However, the SREBP-2 target genes are dysregulated suggesting that elevated copper alters SREBP-2 function rather than its processing or re-localization. Thus, in Atp7b-/- mice elevated copper affects specific cellular targets at the transcription and/or translation levels and has distinct effects on liver metabolic function, prior to appearance of histopathological changes. The identification of the network of specific copper-responsive targets facilitates further mechanistic analysis of human disorders of copper misbalance.",
author = "Dominik Huster and Purnat, {Tina D.} and Burkhead, {Jason L.} and Martina Ralle and Oliver Fiehn and Franziska Stuckert and Olson, {N. Erik} and Daniel Teupser and Svetlana Lutsenko",
year = "2007",
month = "3",
day = "16",
doi = "10.1074/jbc.M607496200",
language = "English (US)",
volume = "282",
pages = "8343--8355",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease

AU - Huster, Dominik

AU - Purnat, Tina D.

AU - Burkhead, Jason L.

AU - Ralle, Martina

AU - Fiehn, Oliver

AU - Stuckert, Franziska

AU - Olson, N. Erik

AU - Teupser, Daniel

AU - Lutsenko, Svetlana

PY - 2007/3/16

Y1 - 2007/3/16

N2 - Copper is essential for human physiology, but in excess it causes the severe metabolic disorder Wilson disease. Elevated copper is thought to induce pathological changes in tissues by stimulating the production of reactive oxygen species that damage multiple cell targets. To better understand the molecular basis of this disease, we performed genome-wide mRNA profiling as well as protein and metabolite analysis for Atp7b-/- mice, an animal model of Wilson disease. We found that at the presymptomatic stages of the disease, copper-induced changes are inconsistent with widespread radical-mediated damage, which is likely due to the sequestration of cytosolic copper by metallothioneins that are markedly up-regulated in Atp7b-/- livers. Instead, copper selectively up-regulates molecular machinery associated with the cell cycle and chromatin structure and down-regulates lipid metabolism, particularly cholesterol biosynthesis. Specific changes in the transcriptome are accompanied by distinct metabolic changes. Biochemical and mass spectroscopy measurements revealed a 3.6-fold decrease of very low density lipoprotein cholesterol in serum and a 33% decrease of liver cholesterol, indicative of a marked decrease in cholesterol biosynthesis. Consistent with low cholesterol levels, the amount of activated sterol regulatory-binding protein 2 (SREBP-2) is increased in Atp7b-/- nuclei. However, the SREBP-2 target genes are dysregulated suggesting that elevated copper alters SREBP-2 function rather than its processing or re-localization. Thus, in Atp7b-/- mice elevated copper affects specific cellular targets at the transcription and/or translation levels and has distinct effects on liver metabolic function, prior to appearance of histopathological changes. The identification of the network of specific copper-responsive targets facilitates further mechanistic analysis of human disorders of copper misbalance.

AB - Copper is essential for human physiology, but in excess it causes the severe metabolic disorder Wilson disease. Elevated copper is thought to induce pathological changes in tissues by stimulating the production of reactive oxygen species that damage multiple cell targets. To better understand the molecular basis of this disease, we performed genome-wide mRNA profiling as well as protein and metabolite analysis for Atp7b-/- mice, an animal model of Wilson disease. We found that at the presymptomatic stages of the disease, copper-induced changes are inconsistent with widespread radical-mediated damage, which is likely due to the sequestration of cytosolic copper by metallothioneins that are markedly up-regulated in Atp7b-/- livers. Instead, copper selectively up-regulates molecular machinery associated with the cell cycle and chromatin structure and down-regulates lipid metabolism, particularly cholesterol biosynthesis. Specific changes in the transcriptome are accompanied by distinct metabolic changes. Biochemical and mass spectroscopy measurements revealed a 3.6-fold decrease of very low density lipoprotein cholesterol in serum and a 33% decrease of liver cholesterol, indicative of a marked decrease in cholesterol biosynthesis. Consistent with low cholesterol levels, the amount of activated sterol regulatory-binding protein 2 (SREBP-2) is increased in Atp7b-/- nuclei. However, the SREBP-2 target genes are dysregulated suggesting that elevated copper alters SREBP-2 function rather than its processing or re-localization. Thus, in Atp7b-/- mice elevated copper affects specific cellular targets at the transcription and/or translation levels and has distinct effects on liver metabolic function, prior to appearance of histopathological changes. The identification of the network of specific copper-responsive targets facilitates further mechanistic analysis of human disorders of copper misbalance.

UR - http://www.scopus.com/inward/record.url?scp=34247198352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247198352&partnerID=8YFLogxK

U2 - 10.1074/jbc.M607496200

DO - 10.1074/jbc.M607496200

M3 - Article

VL - 282

SP - 8343

EP - 8355

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 11

ER -